Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi.
Spider venoms are rich sources of peptidic ion channel modulators with important therapeutical potential. We screened a panel of 60 spider venoms to find modulators of ion channels involved in pain transmission. We isolated, synthesized and pharmacologically characterized Cd1a, a novel peptide from...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5589098?pdf=render |
| _version_ | 1811197364402126848 |
|---|---|
| author | Silmara R Sousa Joshua S Wingerd Andreas Brust Christopher Bladen Lotten Ragnarsson Volker Herzig Jennifer R Deuis Sebastien Dutertre Irina Vetter Gerald W Zamponi Glenn F King Paul F Alewood Richard J Lewis |
| author_facet | Silmara R Sousa Joshua S Wingerd Andreas Brust Christopher Bladen Lotten Ragnarsson Volker Herzig Jennifer R Deuis Sebastien Dutertre Irina Vetter Gerald W Zamponi Glenn F King Paul F Alewood Richard J Lewis |
| author_sort | Silmara R Sousa |
| collection | DOAJ |
| description | Spider venoms are rich sources of peptidic ion channel modulators with important therapeutical potential. We screened a panel of 60 spider venoms to find modulators of ion channels involved in pain transmission. We isolated, synthesized and pharmacologically characterized Cd1a, a novel peptide from the venom of the spider Ceratogyrus darlingi. Cd1a reversibly paralysed sheep blowflies (PD50 of 1318 pmol/g) and inhibited human Cav2.2 (IC50 2.6 μM) but not Cav1.3 or Cav3.1 (IC50 > 30 μM) in fluorimetric assays. In patch-clamp electrophysiological assays Cd1a inhibited rat Cav2.2 with similar potency (IC50 3 μM) without influencing the voltage dependence of Cav2.2 activation gating, suggesting that Cd1a doesn't act on Cav2.2 as a classical gating modifier toxin. The Cd1a binding site on Cav2.2 did not overlap with that of the pore blocker ω-conotoxin GVIA, but its activity at Cav2.2-mutant indicated that Cd1a shares some molecular determinants with GVIA and MVIIA, localized near the pore region. Cd1a also inhibited human Nav1.1-1.2 and Nav1.7-1.8 (IC50 0.1-6.9 μM) but not Nav1.3-1.6 (IC50 > 30 μM) in fluorimetric assays. In patch-clamp assays, Cd1a strongly inhibited human Nav1.7 (IC50 16 nM) and produced a 29 mV depolarising shift in Nav1.7 voltage dependence of activation. Cd1a (400 pmol) fully reversed Nav1.7-evoked pain behaviours in mice without producing side effects. In conclusion, Cd1a inhibited two anti-nociceptive targets, appearing to interfere with Cav2.2 inactivation gating, associated with the Cav2.2 α-subunit pore, while altering the activation gating of Nav1.7. Cd1a was inactive at some of the Nav and Cav channels expressed in skeletal and cardiac muscles and nodes of Ranvier, apparently contributing to the lack of side effects at efficacious doses, and suggesting potential as a lead for development of peripheral pain treatments. |
| first_indexed | 2024-04-12T01:13:28Z |
| format | Article |
| id | doaj.art-739147efa85f406e86cc995223dbb6ee |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-12T01:13:28Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-739147efa85f406e86cc995223dbb6ee2022-12-22T03:54:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018284810.1371/journal.pone.0182848Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi.Silmara R SousaJoshua S WingerdAndreas BrustChristopher BladenLotten RagnarssonVolker HerzigJennifer R DeuisSebastien DutertreIrina VetterGerald W ZamponiGlenn F KingPaul F AlewoodRichard J LewisSpider venoms are rich sources of peptidic ion channel modulators with important therapeutical potential. We screened a panel of 60 spider venoms to find modulators of ion channels involved in pain transmission. We isolated, synthesized and pharmacologically characterized Cd1a, a novel peptide from the venom of the spider Ceratogyrus darlingi. Cd1a reversibly paralysed sheep blowflies (PD50 of 1318 pmol/g) and inhibited human Cav2.2 (IC50 2.6 μM) but not Cav1.3 or Cav3.1 (IC50 > 30 μM) in fluorimetric assays. In patch-clamp electrophysiological assays Cd1a inhibited rat Cav2.2 with similar potency (IC50 3 μM) without influencing the voltage dependence of Cav2.2 activation gating, suggesting that Cd1a doesn't act on Cav2.2 as a classical gating modifier toxin. The Cd1a binding site on Cav2.2 did not overlap with that of the pore blocker ω-conotoxin GVIA, but its activity at Cav2.2-mutant indicated that Cd1a shares some molecular determinants with GVIA and MVIIA, localized near the pore region. Cd1a also inhibited human Nav1.1-1.2 and Nav1.7-1.8 (IC50 0.1-6.9 μM) but not Nav1.3-1.6 (IC50 > 30 μM) in fluorimetric assays. In patch-clamp assays, Cd1a strongly inhibited human Nav1.7 (IC50 16 nM) and produced a 29 mV depolarising shift in Nav1.7 voltage dependence of activation. Cd1a (400 pmol) fully reversed Nav1.7-evoked pain behaviours in mice without producing side effects. In conclusion, Cd1a inhibited two anti-nociceptive targets, appearing to interfere with Cav2.2 inactivation gating, associated with the Cav2.2 α-subunit pore, while altering the activation gating of Nav1.7. Cd1a was inactive at some of the Nav and Cav channels expressed in skeletal and cardiac muscles and nodes of Ranvier, apparently contributing to the lack of side effects at efficacious doses, and suggesting potential as a lead for development of peripheral pain treatments.http://europepmc.org/articles/PMC5589098?pdf=render |
| spellingShingle | Silmara R Sousa Joshua S Wingerd Andreas Brust Christopher Bladen Lotten Ragnarsson Volker Herzig Jennifer R Deuis Sebastien Dutertre Irina Vetter Gerald W Zamponi Glenn F King Paul F Alewood Richard J Lewis Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. PLoS ONE |
| title | Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. |
| title_full | Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. |
| title_fullStr | Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. |
| title_full_unstemmed | Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. |
| title_short | Discovery and mode of action of a novel analgesic β-toxin from the African spider Ceratogyrus darlingi. |
| title_sort | discovery and mode of action of a novel analgesic β toxin from the african spider ceratogyrus darlingi |
| url | http://europepmc.org/articles/PMC5589098?pdf=render |
| work_keys_str_mv | AT silmararsousa discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT joshuaswingerd discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT andreasbrust discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT christopherbladen discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT lottenragnarsson discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT volkerherzig discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT jenniferrdeuis discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT sebastiendutertre discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT irinavetter discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT geraldwzamponi discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT glennfking discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT paulfalewood discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi AT richardjlewis discoveryandmodeofactionofanovelanalgesicbtoxinfromtheafricanspiderceratogyrusdarlingi |